{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:59:02Z","timestamp":1779908342551,"version":"3.53.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1996,2,1]],"date-time":"1996-02-01T00:00:00Z","timestamp":823132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[1996,2]]},"DOI":"10.1007\/bf00168630","type":"journal-article","created":{"date-parts":[[2004,11,6]],"date-time":"2004-11-06T06:33:52Z","timestamp":1099722832000},"page":"290-294","source":"Crossref","is-referenced-by-count":22,"title":["The moderate affinity of clozapine at H3 receptors is not shared by its two major metabolites and by structurally related and unrelated atypical neuroleptics"],"prefix":"10.1007","volume":"353","author":[{"given":"E.","family":"Schlicker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Marr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/npp.1993.50","volume":"9","author":"RJ Baldessarini","year":"1993","unstructured":"Baldessarini RJ, Centorrino F, Flood JG, Volpicelli SA, Houston-Lyons D, Cohen BM (1993) Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology 9:117?124","journal-title":"Neuropsychopharmacology"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248?254","journal-title":"Anal Biochem"},{"key":"CR3","first-page":"283","volume-title":"Handbook of experimental pharmacology, vol XXXIII","author":"RF Furchgott","year":"1972","unstructured":"Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Handbook of experimental pharmacology, vol XXXIII. Springer, Berlin Heidelberg New York, pp 283?335"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/BF00173209","volume":"348","author":"M Kathmann","year":"1993","unstructured":"Kathmann M, Schlicker E, Detzner M, Timmerman H (1993) Nordimaprit, homodimaprit, clobenpropit and imetit: affinities for H3 binding sites and potencies in a functional H3-receptor model. Naunyn-Schmiedeberg's Arch Pharmacol 348:498?503","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/BF02247479","volume":"116","author":"M Kathmann","year":"1994","unstructured":"Kathmann M, Schlicker E, Gothert M (1994) Intermediate affinity and potency of clozapine and low affinity of other neuroleptics and of antidepressants at H3 receptors. Psychopharmacology 116:464?468","journal-title":"Psychopharmacology"},{"key":"CR6","first-page":"127","volume":"39","author":"R Leurs","year":"1992","unstructured":"Leurs R, Timmerman H (1992) The histamine H3-receptor: a target for developing new drugs. Prog Drug Res 39:127?165","journal-title":"Prog Drug Res"},{"key":"CR7","first-page":"57","volume-title":"The histamine receptor","author":"R Lipp","year":"1992","unstructured":"Lipp R, Stark H, Schunack W (1992) Pharmacochemistry of H3-receptors. In: Schwartz JC, Haas HL (eds) The histamine receptor. Wiley-Liss, New York, pp 57?72"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0006-3223(91)90290-3","volume":"30","author":"T Nakai","year":"1991","unstructured":"Nakai T, Kitamura N, Hashimoto T, Kajimoto Y, Nishino N, Mita T, Takana C (1991) Decreased histamine H1 receptors in the frontal cortex of brains from patients with chronic schizophrenia. Biol Psychiat 30:349?356","journal-title":"Biol Psychiat"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0920-9964(94)00034-6","volume":"14","author":"GD Prell","year":"1995","unstructured":"Prell GD, Green JP, Kaufmann CA, Khandelwal JK, Morrishow AM, Kirch DG, Linnoila M, Wyatt RJ (1995) Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophr Res 14: 93?104","journal-title":"Schizophr Res"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/j.1476-5381.1995.tb14934.x","volume":"114","author":"AA Rodrigues","year":"1995","unstructured":"Rodrigues AA, Jansen FP, Leurs R, Timmerman H, Prell GD (1995) Interaction of clozapine with the histamine H3 receptor in rat brain. Br J Pharmacol 114:1523?1524","journal-title":"Br J Pharmacol"},{"key":"CR11","first-page":"489","volume":"345","author":"E Schlicker","year":"1992a","unstructured":"Schlicker E, Behling A, Lummen G, G\u00f6thert M (1992a) Histamine H3A receptor-mediated inhibition of noradrenaline release in the mouse brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 345:489?493","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/BF00164577","volume":"345","author":"E Schlicker","year":"1992b","unstructured":"Schlicker E, Behling A, Lummen G, Malinowska B, G\u00f6thert M (1992b) Mutual interaction of histamine H3-receptors and ?2-adrenoceptors on noradrenergic terminals in mouse and rat brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 345:639?646","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF00180008","volume":"350","author":"E Schlicker","year":"1994","unstructured":"Schlicker E, Kathmann M, Detzner M, Exner HJ, Gothert M (1994) H3 receptor-mediated inhibition of noradrenaline release: an investigation into the involvement of Ca2+ and K+ ions, G protein and adenylate cyclase. Naunyn-Schmiedeberg's Arch Pharmacol 350:34?41","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR14","first-page":"R24","volume":"352","author":"E Schlicker","year":"1995","unstructured":"Schlicker E, Marr I (1995) Affinities of the two major metabolites of clozapine and of a series of atypical neuroleptics for H3 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 352 [Suppl]:R24","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR15","first-page":"397","volume-title":"Psychopharmacology: the fourth generation of progress","author":"JC Schwartz","year":"1995","unstructured":"Schwartz JC, Arrang JM, Garbarg M, Traiffort E (1995) Histamine. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven, New York, pp 397?405"},{"key":"CR16","first-page":"261","volume":"7","author":"P Seeman","year":"1992","unstructured":"Seeman P (1992) Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology 7:261?284","journal-title":"Neuropsychopharmacology"},{"key":"CR17","first-page":"610","volume":"38","author":"RE West","year":"1990","unstructured":"West RE, Zweig A, Shih NY, Siegel MI, Egan RW, Clark MA (1990) Identification of two H3-histamine receptor subtypes. Mol Pharmacol 38:610?613","journal-title":"Mol Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00168630\/fulltext.html","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00168630.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00168630\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00168630","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T08:15:03Z","timestamp":1554279303000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00168630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,2]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1996,2]]}},"alternative-id":["BF00168630"],"URL":"https:\/\/doi.org\/10.1007\/bf00168630","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,2]]}}}